+++ Successful year for the Munich biotech hub ++++++ adivo’s lead oncology program granted limited marketing authorization by EMA ++++++ Helmholtz Munich: New high-tech approach to detect diseased cells at an early stage ++++++ 4GENE closes high six-figure financing round ++++++ AMSilk relocates from IZB to larger premises with plans to scale-up its production of sustainable material solutions ++++++ Immunic Secures USD 60 Million PIPE Financing +++
